Regulation of Catechins and Their Derivatives as Radical Scavengers in Breast Cancer Treatment: A Systematic Literature Review

Read full text Summarise with VIRAT
Authors: Rudi Gunawan, Febby Pratama, Luthfi Utami Setyawati, Dhania Novitasari, Isti Daruwati, Iwan Benny Purwowidodo, Nur Kusaira Khairul Ikram, Muchtaridi , Meike Rachmawati
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This project presents a systematic literature review (SLR) focusing on the therapeutic potential of catechins and their derivatives in breast cancer management. Breast cancer remains a leading cause of global morbidity, where oxidative stress significantly contributes to tumor initiation, progression, and resistance to therapy. This study specifically investigates how these plant-derived flavan-3-ols function as redox modulators. The primary objective is to evaluate experimental evidence published between 2015 and 2025 concerning the radical-scavenging activity of catechins in various breast cancer models. Following PRISMA guidelines, the research seeks to answer whether catechins or their derivatives improve oxidative stress regulation and anticancer outcomes compared to untreated controls. The review explores several key molecular mechanisms, including: - Direct neutralization of reactive oxygen species (ROS). - Modulation of endogenous antioxidant defenses, such as the Nrf2/ARE signaling pathway. - Context-dependent pro-oxidant effects that selectively induce apoptosis in malignant cells. - Epigenetic regulation and interference with oncogenic signaling networks like PI3K/Akt and NF-κB. This research aims to establish a unified mechanistic framework linking redox imbalance to catechin-mediated anticancer effects. Expected insights include: - Identification of specific catechin derivatives, such as epigallocatechin-3-gallate (EGCG), with high biological potency. - Assessment of catechins as adjuvants to enhance the efficacy of conventional treatments (chemotherapy, radiotherapy, and endocrine therapy) while potentially reducing systemic toxicity. - A strategic overview of bioavailability improvements through nanotechnology and delivery-optimized formulations. Ultimately, this project highlights catechins as mechanism-driven redox modulators that can exploit the oxidative vulnerabilities of breast cancer cells for precision therapy.

Fields of Study & Subjects

Phytochemicals and Antioxidant Activities Tea Polyphenols and Effects Free Radicals and Antioxidants

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint